Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.
about
Rickettsia Phylogenomics: Unwinding the Intricacies of Obligate Intracellular LifeLongitudinal characterization of antimicrobial resistance genes in feces shed from cattle fed different subtherapeutic antibioticsMolecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complexThe effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing.Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae.Intravenous azithromycin.A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenesIn vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.Recent progress in novel macrolides, quinolones, and 2-pyridones to overcome bacterial resistance.Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and childrenPrevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm(B) genes.Identification of a streptogramin A acetyltransferase gene in the chromosome of Yersinia enterocolitica.Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureusActivities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan.Quinupristin-Dalfopristin.Identification of essential residues in the Erm(B) rRNA methyltransferase of Clostridium perfringens.An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristinNovel streptogramin antibiotics.Overcoming antimicrobial resistance by targeting resistance mechanisms.Mechanisms of bacterial biocide and antibiotic resistance.Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae.Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux systemDetection of erythromycin-resistant determinants by PCR.Induction of ermSV by 16-membered-ring macrolide antibioticsPharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.Azithromycin: the first azalide antibiotic.Cloning and sequence analysis of ermQ, the predominant macrolide-lincosamide-streptogramin B resistance gene in Clostridium perfringensErythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance.Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 System: comparison with results obtained with the Vitek-2 and Phoenix systemsResistance Genes Underlying the LSA Phenotype of Staphylococcal Isolates from France.Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, ChinaLincosamides, Streptogramins, Phenicols, and Pleuromutilins: Mode of Action and Mechanisms of Resistance.
P2860
Q27487856-2474D035-24FF-40AE-9EB5-1EBDB8B2F5BAQ28386190-CC77F75F-9EC6-43C6-8A3F-BE014B3152F7Q28487335-2FBD69F1-F7E9-41EB-9F4A-E8CE5F1E6189Q30874949-04649514-E7FD-4675-90BB-123D3E6A75CEQ32157959-B86493FA-D829-45C9-BB99-7CD397C26721Q33543121-7A7967A4-36B5-4C8B-9CA2-047B8643B41BQ33689490-E9C348F5-8D3B-47CE-A22F-4AD66F44EC61Q33695123-132FD70A-8073-4B7D-91BF-88DCF65E6D4DQ33771929-390CF1BE-1937-4AE4-A366-A9D953691500Q33785512-0FD84879-E89F-4DDA-AF77-F7607AF9357AQ33938273-C6FC3116-D5E2-4C67-B1D9-5AEBF94FDC4AQ33966765-9E4D7742-0C86-4D9D-AB0D-8B370C255A3BQ33968036-C30DDE8F-1C80-41AF-91C6-CE8FDE58D545Q33977860-B8746C25-10C2-420C-BC9A-5B91880241C0Q33978773-A303DF0E-5564-4290-B8AA-12D8A9BF92EFQ33979098-F4503152-BFAF-4CBE-A7BA-4EA121F6DE03Q33979371-1C3144B5-BF7F-487F-9737-9BEB124FEACBQ33981950-D18B8864-5047-49CA-9567-504E78FB2ECDQ33983537-4E3016A1-C45D-4D3B-91DD-0AE325186D50Q34092244-57CAE352-7A0F-4EE0-A712-AF1C7547FE55Q34107699-E01B48D9-1013-43DF-B059-E7C551E381FCQ34109292-8E3BAF7E-E399-471D-A066-FA036BA60F70Q34141055-4FD9FF48-5CBF-4848-848B-E8F5C98CC645Q34211132-CF7822FB-D7B0-44A4-B10E-D0B6C1F6D187Q34631438-818F4267-BF13-4BA3-9BA4-D1056711C27DQ34643657-66C773A9-1738-45A6-BEF0-F3C0AE1395CAQ34927077-34A1B28C-2162-4470-90CC-0162A0B55384Q35063708-F55A24B0-DC2B-4F1E-80F8-AE70EDE05F8DQ35111936-BC5302FC-920D-45C2-87B0-3963790CA2FAQ35125999-5F329077-0218-4A52-8F67-199723D9230CQ35129238-3480C43E-AF5D-4D0F-908E-5108654AA8A5Q35133337-79E141E2-4FF6-4722-B539-EA21FF3E1567Q35136776-C3F45F90-BDFB-4B45-A385-0D93CA38893BQ35234822-5DB72DD4-A42E-4066-BFA8-3A798FCFEBC8Q35820486-A2272C17-2BE9-494D-89A2-D8F40328D4D2Q35897251-1666C091-4313-44DB-802B-7FE57A4871FBQ36891669-DD8AE107-7BD5-4B8E-9EC0-F62DBE2DC9E4Q37124080-BF4FBB28-0301-40AE-9450-1CB1FDC9B8CDQ37568392-A3906A05-E7B1-47E9-AD6D-04460A8B9DA6Q38934153-B4C7BE6A-E851-40A2-9E90-A3B57A267501
P2860
Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intrinsic and unusual resistan ...... ramin antibiotics in bacteria.
@en
Intrinsic and unusual resistan ...... ramin antibiotics in bacteria.
@nl
type
label
Intrinsic and unusual resistan ...... ramin antibiotics in bacteria.
@en
Intrinsic and unusual resistan ...... ramin antibiotics in bacteria.
@nl
prefLabel
Intrinsic and unusual resistan ...... ramin antibiotics in bacteria.
@en
Intrinsic and unusual resistan ...... ramin antibiotics in bacteria.
@nl
P2860
P356
P1476
Intrinsic and unusual resistan ...... ramin antibiotics in bacteria.
@en
P2093
Courvalin P
Leclercq R
P2860
P304
P356
10.1128/AAC.35.7.1273
P407
P577
1991-07-01T00:00:00Z